Results 131 to 140 of about 110,223 (206)

Real‐world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry

ESC Heart Failure, EarlyView.
Abstract Aims Cardiac resynchronization therapy (CRT) is guideline recommended for the treatment of symptomatic heart failure (HF) with reduced left ventricular ejection fraction and prolonged QRS. However, patients with common comorbidities, such as persistent/permanent atrial fibrillation (AF), are often under‐represented in clinical trials.
Ignacio García‐Bolao, Roy S. Gardner, Daniel Gras, Antonio D'Onofrio, George Mark, Devi Nair, Nicolas Lellouche, Miroslav Novak, Ronald Lo, Engwooi Chew, David Wright, Andrew Kaplan, Matteo Bertini, Sara Veraghtert, Michelle M. Harbin, Elizabeth Matznick, Patrick Yong, Kenneth M. Stein   +17 more
wiley   +1 more source

Oscillatory Nature of AV Nodal Pacemaker Activity

, 1969
Shigetoshi Chiba, Kazubiro Ohkuda, Koroku Hashimoto   +2 more
openalex   +2 more sources

Design and rationale of the eLym™ System for Decompensation of Excess Lymphatic Fluid via the Thoracic Duct in Acute Heart Failure (DELTA‐HF)

ESC Heart Failure, EarlyView.
Abstract Aims The interstitial space is the major compartment in which the excess fluid is located, forming peripheral congestion in acute decompensated heart failure (ADHF). The lymphatic system is responsible for the constant drainage of the compartment.
Jan Biegus, JoAnn Lindenfeld, G. Michael Felker, George Bakris, Michael Jonas, Anuradha Lala, Zviad Kereselidze, George Khabeishvili, Irakli Gogorishvili, Julio Núñez, Antoni Bayés‐Genís, Piotr Ponikowski, William T. Abraham   +12 more
wiley   +1 more source

Early genetic screening and cardiac intervention in patients with cardiomyopathies in a multidisciplinary clinic

ESC Heart Failure, EarlyView.
Abstract Aims Patients with cardiomyopathies are a heterogeneous group of patients who experience high morbidity and mortality. Early cardiac assessment and intervention with access to genetic counselling in a multidisciplinary Cardiomyopathy Clinic may improve outcomes and prevent progression to advanced heart failure.
Chandu Sadasivan, Luke R. Gagnon, Deepan Hazra, Kaiming Wang, Erik Youngson, Jissy Thomas, Anita Y.M. Chan, D. Ian Paterson, Finlay A. McAlister, Tara Dzwiniel, Wayne Tymchak, Susan Christian, Gavin Y. Oudit   +12 more
wiley   +1 more source

Result of a British Survey on Artificial Cardiac Pacemakers [PDF]

, 1968
E Sowton
openalex   +1 more source

Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re‐PHIRE

ESC Heart Failure, EarlyView.
Abstract Aims Despite receiving guideline‐directed medical heart failure (HF) therapy, patients with pulmonary hypertension associated with left heart disease (PH‐LHD) experience higher mortality and hospitalization rates than the general HF population.
Marcin Ufnal, Kathleen Connolly, Marcus Millegard, Elena Surkova, Marco Guazzi, Diana Bonderman, Justin Ezekowitz, Finn Gustafsson, Michał Ciurzyński, Raquel López Vilella, Tariq Ahmad, Roy Gardner, Pavel Jansa, Sandra van Wijk, Koichiro Kinugawa, Erik Björklund, Zhi‐Cheng Jing, Stephan Rosenkranz   +17 more
wiley   +1 more source

Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion

Molecular Genetics &Genomic Medicine, Volume 11, Issue 1, January 2023., 2023
Novel 5,9 kb mtDNA deletion was identified for a 20‐year‐old male who presented with classic Kearns‐Sayre syndrome. Different molecular genetic methods were applied to identify the mitochondrial DNA deletion, but obtaining conflicting research results demonstrated the importance of choosing relevant molecular genetic methods. Abstract Background Kearns‐
Kristina Grigalionienė, Birutė Burnytė, Danutė Balkelienė, Laima Ambrozaitytė, Algirdas Utkus   +4 more
wiley   +1 more source

Treatment of Congenital and Acquired Heart Block with an Implantable Pacemaker [PDF]

, 1964
Rodman E. Taber, LUDOVICO R. ESTOYE, EDWARD R. GREEN, Thomas Gahagan   +3 more
openalex   +1 more source

Treatment patterns, outcomes and healthcare resource utilization of obstructive hypertrophic cardiomyopathy in England

ESC Heart Failure, EarlyView.
Abstract Aims Describe patient characteristics, treatment patterns, clinical outcomes, healthcare resource utilization (HCRU) and medical costs associated with patients who were diagnosed with obstructive hypertrophic cardiomyopathy (HCM) in clinical practice in England.
Faizel Osman, Carla L. Zema, Michael Hurst, Belinda Sandler, Florence Brellier, Ovie Utuama, Oksana Kirichek, John Houghton, Teresa Lemmer, Maite Tome Esteban   +9 more
wiley   +1 more source

Myotonic dystrophy type 1: A comparison between the adult‐ and late‐onset subtype

Muscle &Nerve, Volume 67, Issue 2, Page 130-137, February 2023., 2023
Abstract Introduction/Aims Although the extent of muscle weakness and organ complications has not been well studied in patients with late‐onset myotonic dystrophy type 1 (DM1), adult‐onset DM1 is associated with severe muscle involvement and possible life‐threatening cardiac and respiratory complications.
Isis B.T. Joosten, Corinne G. C. Horlings, Bettine A. H. Vosse, Anouk Wagner, David S. H. Bovenkerk, Reinder Evertz, Kevin Vernooy, Baziel G. M. van Engelen, Catharina G. Faber   +8 more
wiley   +1 more source